Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAAD-VT
NCT05524077Active, not recruiting
- Sponsor
- Western Sydney Local Health District
- Start
- Jul 2020
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Randomised, open-label trial in ventricular tachycardia (VT) and structural heart disease (2 arms), sponsored by Western Sydney Local Health District. Primary endpoints: Composite of Recurrent Ventricular Tachycardia or Ventricular Tachycardia storm at 36 months and Death at 36 months. Started Jul 2020; status: active, not recruiting.
02
Conditions
ventricular tachycardia (VT)structural heart disease
Beyond the preview
Go deeper on NCT05524077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05524077.